Capsules vs Liposomal: Tested Route, or Bet at Double
The decision every basket reaches — hard only because pricing pretended the science was settled. Defaults follow evidence; premiums need reasons you can name.
At a glance
- The fork: tested route at the floor vs mechanism bet at 1.5-2.5×
- The asymmetry: stores trial = plain capsules · liposomal = plasma windows + plausibility
- The two named liposomal buyers: the capsule-averse · the knowing bettor
- The default: capsules — pay premiums only for reasons you can name
The fork, laid out properly
This is the format decision every glutathione basket eventually reaches, so it gets its own page with the evidence asymmetry stated first: the plain-capsule file contains the category's foundational finding — the six-month trial that measured body stores rising on daily oral GSH used plain, non-liposomal capsules (that trial, the absorption history it settled); the liposomal file contains mechanism plausibility (lipid vesicles shielding the molecule through digestion — elegant, coherent) plus smaller, shorter, mostly plasma-window studies — suggestive support for a delivery story, without the head-to-head stores trial that would settle it (the complete audit). Priced onto that asymmetry: plain capsules at the honest floor (~77p — that benchmark) versus liposomal at £1.20-1.80/day — a 1.5-2.5× premium on an open question, which is the fork's entire content: tested route at cost, or plausible upgrade at double.
The two honest liposomal buyers — named, not caricatured
The premium lane's legitimate customers, because a fair fork-page names them: the capsule-averse — for whom flavoured sachets are adherence technology, not indulgence: a stores strategy is a daily pattern across months (the architecture), a format that gets taken beats a format that gets skipped at any price ratio, and this site prints that clause in both directions (the reverse clause's home); and the knowing mechanism-bettor — who has read the open question, understands the premium buys a bet plus an experience rather than a proven outcome, and chooses the vesicles anyway: a defensible speculative position taken with eyes open, with the lane's own honest ranking (Zooki for most, Altrient for heritage) waiting once the choice is made. Everyone outside those two descriptions is a default buyer — and the fork's resolution for defaults is structural: defaults follow evidence, and the evidence's format is the capsule.
Futuro Labs Glutathione
£22.99 for 30-day supply · 77p per day
Pros
- 500mg reduced glutathione (GSH) per serving — the active form
- UK manufactured under GMP certification
- Single-ingredient, vegan, no fillers
- Independently lab tested — microbiology and heavy metals
- ~77p per day vs £1.20-1.80/day for liposomal formats
Cons
- Capsule format — no liposomal delivery system
- Newer brand versus heritage names like Solgar
Available from: Amazon UK — £22.99
The default worked, the upgrade clause, and the close
The capsule default, specified: Futuro Labs Glutathione — 500mg reduced glutathione per plain capsule (the trial's format at the studied window's middle), single-ingredient vegan, independent heavy-metals and microbiology testing shown, £22.99/30 days at ~77p (the record, the lane's best-of) — run on the clock both formats share (8-12 weeks minimum, 3-6 months full curve — the timeline). The upgrade clause, held open as this cluster always holds it: if the settling head-to-head ever arrives and favours the vesicles, stores strategies transfer between formats without ceremony — switch then, having defaulted to evidence meanwhile, with nothing lost but the premium you didn't pay. Constants across the fork: zero authorised claims in any format (the spine), quiet stores everywhere, and the gates — pregnancy/breastfeeding → medical advice; prescription medication → pharmacist minute (the routing). Capsules versus liposomal, closed: an asymmetry, two named exceptions, one structural default — and a fork that was only ever hard because the pricing pretended the science was settled.
Frequently asked questions
Glutathione capsules or liposomal — which should I choose?
The fork in one line: capsules are the evidence's route (the foundational six-month stores trial used plain capsules) at the honest floor (~77p); liposomal is the mechanism bet (plausible enhanced absorption, unsettled science) at 1.5-2.5× the price plus, for sachet formats, a genuine adherence advantage for the capsule-averse. Default to the tested route; pay the premium only for a reason you can name.
Is there any head-to-head evidence?
Not on the endpoint that matters: no trial has run liposomal versus plain GSH head-to-head, months long, with body stores as the outcome. The liposomal file is plasma-window studies plus mechanism plausibility; the plain file is the category's foundational stores finding. That asymmetry is the whole fork.
Who genuinely should pick liposomal?
Two named buyers: the capsule-averse, for whom sachets are adherence technology (a taken habit beats a skipped one at any price ratio), and the knowing mechanism-bettor comfortable paying double for an open question. Everyone else is a default buyer — and defaults follow the evidence's own format.